Analysis of neuronal functions in mice lacking the NMDA receptor ε 1 subunit

Folia Pharmacologica Japonica

Volumn 119, Issue 6, 2002, Pages 327-335

  Miyamoto, Yoshiaki ^a   Nabeshima, Toshitaka ^b  

^a NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Dopaminergic neuronal system; GluR 1 subunit; Hyperlocomotion; Learning and memory; NMDA receptor

Indexed keywords

GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EXPERIMENTAL ANIMAL; GABAERGIC SYSTEM; LEARNING DISORDER; LOCOMOTION; LONG TERM POTENTIATION; MOUSE; NERVE FUNCTION; NEUROTRANSMISSION; NONHUMAN; RECEPTOR INTRINSIC ACTIVITY; REVIEW; SEROTONINERGIC SYSTEM;

ANIMALS; DISEASE MODELS, ANIMAL; MICE; MICE, MUTANT STRAINS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 0036301661     PISSN: 00155691     EISSN: None     Source Type: Journal    
DOI: 10.1254/fpj.119.327     Document Type: Review

References (40)

1. The physiology of excitatory amino acids in the vertebrate central nervous system
2. Cloned glutamate receptors
3. Molecular diversity and functions of glutamate receptors
4. A synaptic model of memory: Long-term potentiation in the hippocampus
5. NMDA-receptor-dependent synaptic plasticity: Multiple forms and mechanisms
6. Excitatory amino acids as a final common pathway for neurologic disorders
7. Molecular diversity of the NMDA receptor channel
8. Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs
9. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes
10. Evidence for a tetrameric structure of recombinant NMDA receptors
11. Biochemical evidence for the co-association of three N-methyl-D-aspartate (NMDA) R2 subunits in recombinant NMDA receptors
12. Developmental changes in distribution of NMDA receptor channel subunit mRNAs
13. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors
14. Cloning and characterization of X-1: A developmentally regulated member of a novel class of the ionotropic glutamate receptor family
15. N-Glycosylation site tagging suggests a three trans-membrane domain topology for the glutamate receptor GluR1
16. Unraveling the modular design of glutamate-gated ion channels
17. Molecular determinants of agonist discrimination by NMDA receptor subunits: Analysis of the glutamate binding site on the NR2B subunit
18. Mutational analysis of the glycine-binding site of the NMDA receptor: Structural similarity with bacterial amino acid-binding proteins
19. Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor
20. 2+-block site of the NMDA receptor channel
21. Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε 1 subunit
22. Increased thresholds for long-term potentiation and contextual learning in mice lacking the NMDA-type glutamate receptor ε 1 subunit
23. Motor discoordination results from combined gene disruption of the NMDA receptor NR2A and NR2C subunits, but not from single disruption of the NR2A or NR2C subunit
24. Functional correlation of NMDA receptor ε subunits expression with the properties of single-channel and synaptic currents in the developing cerebellum
25. Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor ε 1 subunit
26. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine
27. NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus
28. The N-methyl-D-aspartate receptor antagonist MK-801 induces increases in dopamine and serotonin metabolism in several brain regions of rats
29. Roles of the glutamate receptor ε 2 and δ 2 subunits in the potentiation and prepulse inhibition of the acoustic startle reflex
30. Absence of prostaglandin E2-induced hyperalgesia in NMDA receptor ε subunit knockout mice
31. Enhanced nociception by exogenous and endogenous substance P given into the spinal cord in mice lacking NR2A/ε 1, an NMDA receptor subunit
32. Recent advances in the phencyclidine model of schizophrenia
33. Schizophrenia and glutamatergic transmission
34. Antipsychotic drug doses and neuroleptic/dopamine receptors
35. The mechanism of action of novel antipsychotic drugs
36. Effects of risperidone on phencyclidine-induced behaviors: Comparison with haloperidol and ritanserin
37. Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: A new model of schizophrenia
38. Interactions between glutamatergic and monoaminergic systems within the basal ganglia: Implications for schizophrenia and Parkinson's disease
39. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors
40. Attenuation of focal ischemic brain injury in mice deficient in the ε 1 (NR2A) subunit of NMDA receptor